Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

PHASE4CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

carbidopa, levodopa, entacapone

Trial Locations (18)

Unknown

Royal Adelaide Hospital, Adelaide

Watkins Medical Center, Brisbane

Central Coast Neuroscience Research, Gosford

Heidelberg Repatriation Hospital, Melbourne

Monash Medical Centre, Melbourne

Sir Charles Gairdner Hospital, Perth

Concord Hospital, Sydney

Southern Neurology, St. George Private Hospital, Sydney

Westmead Hospital, Sydney

St. Luke's Medical Centre, Manila

University of Santo Tomas Hospital, Manila

Chang Gung Memorial Hospital, Linkou District

Kaohsiung Medical University, Chung-Ho Memorial Hospital, Linkou District

National Taiwan University Hospital, Linkou District

King Chulalongkorn Memorial Hospital, Bangkok

Maharaj Nakorn Chiangmai Hospital, Bangkok

Pharmongkutklao Army Hospital, Bangkok

Siriraj Hospital, Bangkok

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00143026 - Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States | Biotech Hunter | Biotech Hunter